These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 21917862

  • 1. Long-term impact of GH treatment during childhood on body composition and fat distribution in young adults born SGA.
    Breukhoven PE, Kerkhof GF, van Dijk M, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3710-6. PubMed ID: 21917862
    [Abstract] [Full Text] [Related]

  • 2. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH, Arends NJ, Bakker-van Waarde WM, Jansen M, van Mil EG, Mulder J, Odink RJ, Reeser M, Rongen-Westerlaken C, Stokvis-Brantsma WH, Waelkens JJ, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [Abstract] [Full Text] [Related]

  • 3. Influence of birth size on body composition in early adulthood: the programming factors for growth and metabolism (PROGRAM)-study.
    Leunissen RW, Stijnen T, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):245-51. PubMed ID: 18616715
    [Abstract] [Full Text] [Related]

  • 4. Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age.
    Berndt C, Schweizer R, Ranke MB, Binder G, Martin DD.
    Horm Res Paediatr; 2014 Feb; 82(2):81-8. PubMed ID: 24969628
    [Abstract] [Full Text] [Related]

  • 5. Longitudinal changes in insulin sensitivity and body composition of small-for-gestational-age adolescents after cessation of growth hormone treatment.
    Willemsen RH, Willemsen SP, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3449-54. PubMed ID: 18559910
    [Abstract] [Full Text] [Related]

  • 6. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ, van der Kaay DC, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [Abstract] [Full Text] [Related]

  • 7. Fat distribution in short-stature children born small for gestational age.
    Maeyama T, Ida S, Onuma S, Shoji Y, Yamamoto T, Etani Y, Kawai M.
    Pediatr Int; 2020 Dec; 62(12):1351-1356. PubMed ID: 32521070
    [Abstract] [Full Text] [Related]

  • 8. Metabolic Health in Short Children Born Small for Gestational Age Treated With Growth Hormone and Gonadotropin-Releasing Hormone Analog: Results of a Randomized, Dose-Response Trial.
    van der Steen M, Lem AJ, van der Kaay DC, Bakker-van Waarde WM, van der Hulst FJ, Neijens FS, Noordam C, Odink RJ, Oostdijk W, Schroor EJ, Westerlaken C, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3725-34. PubMed ID: 26259134
    [Abstract] [Full Text] [Related]

  • 9. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T, Mulder P, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [Abstract] [Full Text] [Related]

  • 10. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC, van Pareren Y, Sas T, Arends N.
    Horm Res; 2003 Oct; 60 Suppl 3():113-4. PubMed ID: 14671407
    [Abstract] [Full Text] [Related]

  • 11. Abdominal fat partitioning and high-molecular-weight adiponectin in short children born small for gestational age.
    Ibáñez L, López-Bermejo A, Díaz M, Marcos MV, Casano P, de Zegher F.
    J Clin Endocrinol Metab; 2009 Mar; 94(3):1049-52. PubMed ID: 19066297
    [Abstract] [Full Text] [Related]

  • 12. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW, Willemsen RH, van der Kaay DC, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [Abstract] [Full Text] [Related]

  • 13. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F, Du Caju MV, Heinrichs C, Maes M, De Schepper J, Craen M, Vanweser K, Malvaux P, Rosenfeld RG.
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [Abstract] [Full Text] [Related]

  • 14. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R, Martin DD, Schönau E, Ranke MB.
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [Abstract] [Full Text] [Related]

  • 15. Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age.
    van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5295-302. PubMed ID: 15531473
    [Abstract] [Full Text] [Related]

  • 16. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls.
    van Dijk M, Bannink EM, van Pareren YK, Mulder PG, Hokken-Koelega AC.
    J Clin Endocrinol Metab; 2007 Jan; 92(1):160-5. PubMed ID: 17062774
    [Abstract] [Full Text] [Related]

  • 17. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
    Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebl J, Chipman JJ, Shalet SM, Hypopituitary Developmental Outcome Study Group.
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone therapy for children born small for gestational age: height gain is less dose dependent over the long term than over the short term.
    de Zegher F, Hokken-Koelega A.
    Pediatrics; 2005 Apr; 115(4):e458-62. PubMed ID: 15805349
    [Abstract] [Full Text] [Related]

  • 19. Bone Mineral Density After Cessation of GH Treatment in Young Adults Born SGA: A 5-Year Longitudinal Study.
    Smeets CCJ, van der Steen M, Renes JS, Hokken-Koelega ACS.
    J Clin Endocrinol Metab; 2017 Sep 01; 102(9):3508-3516. PubMed ID: 28911145
    [Abstract] [Full Text] [Related]

  • 20. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A, Simon D, Czernichow P.
    J Clin Endocrinol Metab; 2004 Mar 01; 89(3):1234-9. PubMed ID: 15001616
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.